SERPINA7 and cancer: To achieve cancer cell-specific targeting of CK2 using an RNAi strategy, we have employed a novel sub-50 nm sized tenfibgen-based delivery vehicle referred to as s50-TBG or TBG nanocapsule, which is designed to restrict delivery of its cargo to cancer cells.